logo

Susan Greenspan, MD

Susan Greenspan, MD

Endocrinology Pittsburgh, PA

Professor of Medicine, University Pittsburgh

Office Address

Office Map
  • 3471 5th Ave
    Kaufmann Building, Suite 1110
    Pittsburgh, PA 15213
    Phone: (412) 692-2472

Dr. Greenspan's Clinical Specialties & Interests

  • Endocrinology: Diabetes

Dr. Greenspan's Education & Medical Training

  • Massachusetts General HospitalMassachusetts General HospitalFellowship, Endocrinology, Diabetes and Metabolism
  • Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical CenterResidency, Internal Medicine
  • Harvard Med SchHarvard Medical SchoolMedical School

Dr. Greenspan's Certifications & Licensure

  • PA State Medical LicensePA State Medical License1999 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineEndocrinology & Metabolism
  • American Board of Internal MedicineAmerican Board of Internal MedicineGeriatric Medicine

Dr. Greenspan's Awards, Honors, & Recognition

  • Centers for Medicare & Medicaid ServicesMeaningful Use Stage 1 CertificationCenters for Medicare & Medicaid Services, 2011

Dr. Greenspan's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Research Career Development Core
    Research Career Development CoreNational Institute On Aging
    2009 - 2011
  • Maintenance Of Skeletal Integrity In Frail Elders
    Maintenance Of Skeletal Integrity In Frail EldersNational Institute On Aging
    2007 - 2011
  • F/U PTH Alendronate Combo Trmnt Osteoporosis PATH II
    F/U PTH Alendronate Combo Trmnt Osteoporosis PATH IINational Center For Research Resources
    2005 - 2005
  • Bone Loss In Men W/Prostate Cancer Treated W/Androgen Deprivation Therapy
    Bone Loss In Men W/Prostate Cancer Treated W/Androgen Deprivation TherapyNational Center For Research Resources
    2005 - 2005
  • Once Wkly Bisphosphonate Preventing Osteoporosis In Hypogondal Men
    Once Wkly Bisphosphonate Preventing Osteoporosis In Hypogondal MenNational Center For Research Resources
    2005 - 2005
  • Prevention Osteoporosis Premenopausal/Postmenopausal Women W/Breast Cancer
    Prevention Osteoporosis Premenopausal/Postmenopausal Women W/Breast CancerNational Center For Research Resources
    2005 - 2005
  • Bariatric Surgery Effect On Bone Mass/ Bone Metabolism
    Bariatric Surgery Effect On Bone Mass/ Bone MetabolismNational Center For Research Resources
    2004 - 2004
  • Prevention Osteoporosis In Premenopause/Postmenopause
    Prevention Osteoporosis In Premenopause/PostmenopauseNational Center For Research Resources
    2004 - 2004
  • Research And Development Core
    Research And Development CoreNational Institute On Aging
    2004 - 2008
  • PTH And Alendronate In The Treatment Of Osteoporosis
    PTH And Alendronate In The Treatment Of OsteoporosisNational Center For Research Resources
    2004 - 2004
  • Bisphosphonate Prevention Of Osteoporosis In Men
    Bisphosphonate Prevention Of Osteoporosis In MenNational Center For Research Resources
    2004 - 2004
  • Lasofoxifene For Women At Risk For Osteoporosis
    Lasofoxifene For Women At Risk For OsteoporosisNational Center For Research Resources
    2004 - 2004
  • Bone Loss In Men With Prostate Cancer
    Bone Loss In Men With Prostate CancerNational Center For Research Resources
    2004 - 2004
  • Osteoporosis In Older Men And Women
    Osteoporosis In Older Men And WomenNational Institute Of Diabetes And Digestive And Kidney Diseases
    2003 - 2012
  • Prevention Of Osteoporosis In Men With Prostate Cancer
    Prevention Of Osteoporosis In Men With Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases
    2002 - 2005
  • Efficacy Of QUS 2 Ultrasonometer For Diagnosis Of Osteoporosis
    Efficacy Of QUS 2 Ultrasonometer For Diagnosis Of OsteoporosisNational Center For Research Resources
    2000 - 2002
  • Precision Assessment Of QUS 2 Ultrasonometer
    Precision Assessment Of QUS 2 UltrasonometerNational Center For Research Resources
    2000 - 2002
  • Phase III Cyclic Tiludronate--Postmenopausal Osteoporosi
    Phase III Cyclic Tiludronate--Postmenopausal OsteoporosiNational Center For Research Resources
    2000 - 2002
  • Reference Range For The QUS 2 Ultrasonometer For Evaluation Of Osteoporosis
    Reference Range For The QUS 2 Ultrasonometer For Evaluation Of OsteoporosisNational Center For Research Resources
    2000 - 2002
  • Calcaneal Bone Assessment Technologies To Dual X Ray Absorptiometry
    Calcaneal Bone Assessment Technologies To Dual X Ray AbsorptiometryNational Center For Research Resources
    2000 - 2002
  • Screening High Risk Population For Clinically Significant Gaucher DIS
    Screening High Risk Population For Clinically Significant Gaucher DISNational Center For Research Resources
    1999 - 2002
  • Alendronate Once Weekly For Osteoporosis Prevention
    Alendronate Once Weekly For Osteoporosis PreventionNational Center For Research Resources
    1999 - 2002
  • Alendronate Once &Twice Weekly For Osteoporosis Treatment
    Alendronate Once &Twice Weekly For Osteoporosis TreatmentNational Center For Research Resources
    1999 - 2002
  • Alendronate On Bone Density Maintenance In Female Nursing Home Patients
    Alendronate On Bone Density Maintenance In Female Nursing Home PatientsNational Center For Research Resources
    1997 - 2000
  • Efficacy Of Mk-0677 And Alendronate On Bone Turnover And Density
    Efficacy Of Mk-0677 And Alendronate On Bone Turnover And DensityNational Center For Research Resources
    1997 - 2000
  • Bisphosphonate-Hormonal Therapy For Osteoporosis
    Bisphosphonate-Hormonal Therapy For OsteoporosisNational Center For Research Resources
    1997 - 2002
  • Diabetes In A Patient With Osteoporosis
    Diabetes In A Patient With OsteoporosisNational Center For Research Resources
    1997 - 1997
  • Bone Loss Prevention After Acute HIP Fracture In The Elderly
    Bone Loss Prevention After Acute HIP Fracture In The ElderlyNational Center For Research Resources
    1997 - 2000
  • Insulinlike Growth Factor I And Bone Marker Status After HIP Fracture
    Insulinlike Growth Factor I And Bone Marker Status After HIP FractureNational Center For Research Resources
    1997 - 1997
  • Efficacy Of Alendronate On Bone Density Maintenance In Female Nursing Home PTS
    Efficacy Of Alendronate On Bone Density Maintenance In Female Nursing Home PTSNational Center For Research Resources
    1996 - 1996
  • Comparison Of Calcaneal Bone Assessment Technologies To Dual X Ray Absorptiometry
    Comparison Of Calcaneal Bone Assessment Technologies To Dual X Ray AbsorptiometryNational Center For Research Resources
    1996 - 1996
  • Femoral Osteoporosis In Elderly Women
    Femoral Osteoporosis In Elderly WomenNational Institute On Aging
    1995 - 1999
  • Raloxifene Hydrochloride, Placebo And Premarin In Prevention Of Osteoporosis
    Raloxifene Hydrochloride, Placebo And Premarin In Prevention Of OsteoporosisNational Center For Research Resources
    1995 - 2002
  • Effect Of Alendronate, Estrogen And Combination Therapy For Osteoporosis
    Effect Of Alendronate, Estrogen And Combination Therapy For OsteoporosisNational Center For Research Resources
    1995 - 2000
  • Role Of Bisphosphonate Therapy In Maintenance Of Skeletal Integrity
    Role Of Bisphosphonate Therapy In Maintenance Of Skeletal IntegrityNational Center For Research Resources
    1995 - 1997
  • Phase III Study Of Intermittent Cyclical Tiludronate
    Phase III Study Of Intermittent Cyclical TiludronateNational Center For Research Resources
    1995 - 1999
  • Biochemical Correlates Of Bone Loss
    Biochemical Correlates Of Bone LossNational Center For Research Resources
    1995 - 1996
  • HIP Fracture Risk Prediction By Quantitative Digital Radiography
    HIP Fracture Risk Prediction By Quantitative Digital RadiographyNational Center For Research Resources
    1995 - 1995
  • Finasteride Indices On Bone Mineral Metabolism In Benign Prostate Hyperplasia
    Finasteride Indices On Bone Mineral Metabolism In Benign Prostate HyperplasiaNational Center For Research Resources
    1995 - 1995
  • Effect Of Pamidronate On Chronic Thyroid Hormone-Induced Bone Turnover
    Effect Of Pamidronate On Chronic Thyroid Hormone-Induced Bone TurnoverNational Center For Research Resources
    1995 - 1995
  • Diurnal Variation In PTH And Calcium While On Alendronate Therapy
    Diurnal Variation In PTH And Calcium While On Alendronate TherapyNational Center For Research Resources
    1995 - 1995

Dr. Greenspan's Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • HealthAmerica HealthAssurance PPO
  • Highmark BCBS ClassicBlue
  • Highmark BCBS PPOBlue
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Susan Greenspan, Dr. Susan Greenspan, MD, Dr. S Greenspan, Dr. Susan L Greenspan

29 Colleague Invites!
Is this you? If so, register to see 29 messages.

Physicians, view Dr. Greenspan's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV